APA (7th ed.) Citation

S, I., EH, Y., AM, E., NA, R., & AA, A. (2025). Melatonin augments anti-tumor activity and alleviates nephrotoxicity of gemcitabine in a pancreatic cancer xenograft model targeting P62/Keap1 pathway. Naunyn-Schmiedeberg's archives of pharmacology, 398(9), 12069. https://doi.org/10.1007/s00210-025-03938-x

Chicago Style (17th ed.) Citation

S, Ibrahim, Yousef EH, El-Dessouki AM, Raslan NA, and Alzokaky AA. "Melatonin Augments Anti-tumor Activity and Alleviates Nephrotoxicity of Gemcitabine in a Pancreatic Cancer Xenograft Model Targeting P62/Keap1 Pathway." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 9 (2025): 12069. https://doi.org/10.1007/s00210-025-03938-x.

MLA (9th ed.) Citation

S, Ibrahim, et al. "Melatonin Augments Anti-tumor Activity and Alleviates Nephrotoxicity of Gemcitabine in a Pancreatic Cancer Xenograft Model Targeting P62/Keap1 Pathway." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 9, 2025, p. 12069, https://doi.org/10.1007/s00210-025-03938-x.